3.24.1.1.u2 html 78 193 1 false 19 0 false 4 false false R1.htm 000001 - Document - Cover Sheet http://bioadaptives.com/role/Cover Cover Cover 1 false false R2.htm 000002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://bioadaptives.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://bioadaptives.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) Sheet http://bioadaptives.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) Statements 4 false false R5.htm 000005 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS DEFICIT (UNAUDITED) Sheet http://bioadaptives.com/role/ConsolidatedStatementOfStockholdersDeficitUnaudited CONSOLIDATED STATEMENT OF STOCKHOLDERS DEFICIT (UNAUDITED) Statements 5 false false R6.htm 000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOW (UNAUDITED) Sheet http://bioadaptives.com/role/ConsolidatedStatementsOfCashFlowUnaudited CONSOLIDATED STATEMENTS OF CASH FLOW (UNAUDITED) Statements 6 false false R7.htm 000007 - Disclosure - DESCRIPTION OF BUSINESS AND HISTORY Sheet http://bioadaptives.com/role/DescriptionOfBusinessAndHistory DESCRIPTION OF BUSINESS AND HISTORY Notes 7 false false R8.htm 000008 - Disclosure - SUMMARY OF SIGNIFICANT POLICIES Sheet http://bioadaptives.com/role/SummaryOfSignificantPolicies SUMMARY OF SIGNIFICANT POLICIES Notes 8 false false R9.htm 000009 - Disclosure - GOING CONCERN Sheet http://bioadaptives.com/role/GoingConcern GOING CONCERN Notes 9 false false R10.htm 000010 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Sheet http://bioadaptives.com/role/AccountsPayableAndAccruedLiabilities ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Notes 10 false false R11.htm 000011 - Disclosure - CONVERTIBLE NOTES Notes http://bioadaptives.com/role/ConvertibleNotes CONVERTIBLE NOTES Notes 11 false false R12.htm 000012 - Disclosure - DERIVATIVE LIABILITIES Sheet http://bioadaptives.com/role/DerivativeLiabilities DERIVATIVE LIABILITIES Notes 12 false false R13.htm 000013 - Disclosure - STOCKHOLDERS EQUITY Sheet http://bioadaptives.com/role/StockholdersEquity STOCKHOLDERS EQUITY Notes 13 false false R14.htm 000014 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://bioadaptives.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 14 false false R15.htm 000015 - Disclosure - LICENSE AND PATENT Sheet http://bioadaptives.com/role/LicenseAndPatent LICENSE AND PATENT Notes 15 false false R16.htm 000016 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://bioadaptives.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 16 false false R17.htm 000017 - Disclosure - SUBSEQUENT EVENTS Sheet http://bioadaptives.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 17 false false R18.htm 000018 - Disclosure - SUMMARY OF SIGNIFICANT POLICIES (Policies) Sheet http://bioadaptives.com/role/SummaryOfSignificantPoliciesPolicies SUMMARY OF SIGNIFICANT POLICIES (Policies) Policies 18 false false R19.htm 000019 - Disclosure - SUMMARY OF SIGNIFICANT POLICIES (Tables) Sheet http://bioadaptives.com/role/SummaryOfSignificantPoliciesTables SUMMARY OF SIGNIFICANT POLICIES (Tables) Tables http://bioadaptives.com/role/SummaryOfSignificantPolicies 19 false false R20.htm 000020 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables) Sheet http://bioadaptives.com/role/AccountsPayableAndAccruedLiabilitiesTables ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables) Tables http://bioadaptives.com/role/AccountsPayableAndAccruedLiabilities 20 false false R21.htm 000021 - Disclosure - CONVERTIBLE NOTES (Tables) Notes http://bioadaptives.com/role/ConvertibleNotesTables CONVERTIBLE NOTES (Tables) Tables http://bioadaptives.com/role/ConvertibleNotes 21 false false R22.htm 000022 - Disclosure - DERIVATIVE LIABILITIES (Tables) Sheet http://bioadaptives.com/role/DerivativeLiabilitiesTables DERIVATIVE LIABILITIES (Tables) Tables http://bioadaptives.com/role/DerivativeLiabilities 22 false false R23.htm 000023 - Disclosure - STOCKHOLDERS EQUITY (Tables) Sheet http://bioadaptives.com/role/StockholdersEquityTables STOCKHOLDERS EQUITY (Tables) Tables http://bioadaptives.com/role/StockholdersEquity 23 false false R24.htm 000024 - Disclosure - LICENSE AND PATENT (Tables) Sheet http://bioadaptives.com/role/LicenseAndPatentTables LICENSE AND PATENT (Tables) Tables http://bioadaptives.com/role/LicenseAndPatent 24 false false R25.htm 000025 - Disclosure - SUMMARY OF SIGNIFICANT POLICIES (Details) Sheet http://bioadaptives.com/role/SummaryOfSignificantPoliciesDetails SUMMARY OF SIGNIFICANT POLICIES (Details) Details http://bioadaptives.com/role/SummaryOfSignificantPoliciesTables 25 false false R26.htm 000026 - Disclosure - GOING CONCERN (Details Narrative) Sheet http://bioadaptives.com/role/GoingConcernDetailsNarrative GOING CONCERN (Details Narrative) Details http://bioadaptives.com/role/GoingConcern 26 false false R27.htm 000027 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) Sheet http://bioadaptives.com/role/AccountsPayableAndAccruedLiabilitiesDetails ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) Details http://bioadaptives.com/role/AccountsPayableAndAccruedLiabilitiesTables 27 false false R28.htm 000028 - Disclosure - CONVERTIBLE NOTES (Details) Notes http://bioadaptives.com/role/ConvertibleNotesDetails CONVERTIBLE NOTES (Details) Details http://bioadaptives.com/role/ConvertibleNotesTables 28 false false R29.htm 000029 - Disclosure - CONVERTIBLE NOTES (Details Narrative) Notes http://bioadaptives.com/role/ConvertibleNotesDetailsNarrative CONVERTIBLE NOTES (Details Narrative) Details http://bioadaptives.com/role/ConvertibleNotesTables 29 false false R30.htm 000030 - Disclosure - DERIVATIVE LIABILITIES (Details) Sheet http://bioadaptives.com/role/DerivativeLiabilitiesDetails DERIVATIVE LIABILITIES (Details) Details http://bioadaptives.com/role/DerivativeLiabilitiesTables 30 false false R31.htm 000031 - Disclosure - DERIVATIVE LIABILITIES (Details 1) Sheet http://bioadaptives.com/role/DerivativeLiabilitiesDetails1 DERIVATIVE LIABILITIES (Details 1) Details http://bioadaptives.com/role/DerivativeLiabilitiesTables 31 false false R32.htm 000032 - Disclosure - DERIVATIVE LIABILITIES (Details 2) Sheet http://bioadaptives.com/role/DerivativeLiabilitiesDetails2 DERIVATIVE LIABILITIES (Details 2) Details http://bioadaptives.com/role/DerivativeLiabilitiesTables 32 false false R33.htm 000033 - Disclosure - STOCKHOLDERS EQUITY (Details) Sheet http://bioadaptives.com/role/StockholdersEquityDetails STOCKHOLDERS EQUITY (Details) Details http://bioadaptives.com/role/StockholdersEquityTables 33 false false R34.htm 000034 - Disclosure - STOCKHOLDERS EQUITY (Details Narrative) Sheet http://bioadaptives.com/role/StockholdersEquityDetailsNarrative STOCKHOLDERS EQUITY (Details Narrative) Details http://bioadaptives.com/role/StockholdersEquityTables 34 false false R35.htm 000035 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://bioadaptives.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://bioadaptives.com/role/RelatedPartyTransactions 35 false false R36.htm 000036 - Disclosure - LICENSE AND PATENT (Details ) Sheet http://bioadaptives.com/role/LicenseAndPatentDetails LICENSE AND PATENT (Details ) Details http://bioadaptives.com/role/LicenseAndPatentTables 36 false false R37.htm 000037 - Disclosure - LICENSE AND PATENT (Details 1 ) Sheet http://bioadaptives.com/role/LicenseAndPatentDetails1 LICENSE AND PATENT (Details 1 ) Details http://bioadaptives.com/role/LicenseAndPatentTables 37 false false R38.htm 000038 - Disclosure - LICENSE AND PATENT (Details Narrative) Sheet http://bioadaptives.com/role/LicenseAndPatentDetailsNarrative LICENSE AND PATENT (Details Narrative) Details http://bioadaptives.com/role/LicenseAndPatentTables 38 false false R39.htm 000039 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://bioadaptives.com/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://bioadaptives.com/role/CommitmentsAndContingencies 39 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 24 fact(s) appearing in ix:hidden were eligible for transformation: bdpt:CommonStockCapitalSharesReservedForFutureIssuance1, bdpt:PreferredStockAuthorized, bdpt:PreferredStockSharesDesignated, dei:DocumentQuarterlyReport, dei:DocumentTransitionReport, dei:EntityEmergingGrowthCompany, us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount, us-gaap:CommonStockCapitalSharesReservedForFutureIssuance, us-gaap:CommonStockParOrStatedValuePerShare, us-gaap:CommonStockSharesAuthorized, us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:DebtInstrumentTerm, us-gaap:PreferredStockParOrStatedValuePerShare, us-gaap:PreferredStockSharesAuthorized, us-gaap:PreferredStockSharesOutstanding - bdpt_10q.htm 1 [DQC.US.0043.9873] The company has reported the concept ProfitLoss as part of the cash flow statement. This income item is being deducted from the value of operating cash flows in the calculation defined by the filer. This implies that the resulting operating cash flow calculation excludes this income item from cash flow from operations. If ProfitLoss represents income from discontinued operations then the element NetCashProvidedByUsedInOperatingActivitiesContinuingOperations should be used as the total rather than the current total element of NetCashProvidedByUsedInOperatingActivities. If the item is an income item and is being deducted because the value is negative then consider changing the sign and weight of the element. - https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd 4602, 9356 - https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd 4602, 9356 bdpt-20240331.xsd bdpt-20240331_cal.xml bdpt-20240331_def.xml bdpt-20240331_lab.xml bdpt-20240331_pre.xml bdpt_10q.htm bdpt_10qimg3.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true